NO20034356L - Terapeutisk middel for overaktiv bl¶re - Google Patents

Terapeutisk middel for overaktiv bl¶re

Info

Publication number
NO20034356L
NO20034356L NO20034356A NO20034356A NO20034356L NO 20034356 L NO20034356 L NO 20034356L NO 20034356 A NO20034356 A NO 20034356A NO 20034356 A NO20034356 A NO 20034356A NO 20034356 L NO20034356 L NO 20034356L
Authority
NO
Norway
Prior art keywords
overactive
bleeding
therapeutic agent
therapeutic
agent
Prior art date
Application number
NO20034356A
Other languages
English (en)
Norwegian (no)
Other versions
NO20034356D0 (no
Inventor
Tsuyoshi Yamagata
Kaoru Atsuki
Tetsuji Ohno
Shiro Shirakura
Akira Karasawa
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Publication of NO20034356D0 publication Critical patent/NO20034356D0/no
Publication of NO20034356L publication Critical patent/NO20034356L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D337/00—Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
    • C07D337/02—Seven-membered rings
    • C07D337/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D337/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D337/12—[b,e]-condensed

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO20034356A 2001-03-30 2003-09-29 Terapeutisk middel for overaktiv bl¶re NO20034356L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001099801 2001-03-30
PCT/JP2002/003167 WO2002078710A1 (fr) 2001-03-30 2002-03-29 Medicaments contre l'hyperactivite vesicale

Publications (2)

Publication Number Publication Date
NO20034356D0 NO20034356D0 (no) 2003-09-29
NO20034356L true NO20034356L (no) 2003-11-27

Family

ID=18953304

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034356A NO20034356L (no) 2001-03-30 2003-09-29 Terapeutisk middel for overaktiv bl¶re

Country Status (12)

Country Link
US (1) US7276532B2 (ko)
EP (1) EP1384480A1 (ko)
JP (1) JPWO2002078710A1 (ko)
KR (1) KR20040007476A (ko)
CN (1) CN1498110A (ko)
BR (1) BR0208420A (ko)
CA (1) CA2442463A1 (ko)
EA (1) EA200301080A1 (ko)
HU (1) HUP0303608A3 (ko)
MX (1) MXPA03008725A (ko)
NO (1) NO20034356L (ko)
WO (1) WO2002078710A1 (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060205756A1 (en) * 2003-03-31 2006-09-14 Kyowa Hakko Kogyo Co., Ltd. Antitussives
AR044870A1 (es) * 2003-06-27 2005-10-05 Kyowa Hakko Kogyo Kk Compuesto azufrado triciclico y su uso como agente terapeutico para la vejiga hiperactiva
JPWO2005007191A1 (ja) * 2003-07-16 2006-08-31 協和醗酵工業株式会社 医薬組成物
TW200522943A (en) * 2003-12-11 2005-07-16 Kyowa Hakko Kogyo Kk Fine crystallites and a pharmaceutical composition comprising them
TW200827367A (en) * 2006-10-26 2008-07-01 Kyowa Hakko Kogyo Kk A therapeutic agent for irritable bowel syndrome

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997014672A1 (fr) * 1995-10-16 1997-04-24 Kyowa Hakko Kogyo Co. Ltd. Composes tricycliques
CA2286723C (en) * 1997-04-15 2007-01-30 Kyowa Hakko Kogyo Co., Ltd. Tricyclic compounds

Also Published As

Publication number Publication date
CA2442463A1 (en) 2002-10-10
NO20034356D0 (no) 2003-09-29
EP1384480A1 (en) 2004-01-28
HUP0303608A2 (hu) 2004-03-01
KR20040007476A (ko) 2004-01-24
MXPA03008725A (es) 2004-04-05
EA200301080A1 (ru) 2004-04-29
CN1498110A (zh) 2004-05-19
JPWO2002078710A1 (ja) 2004-07-22
US7276532B2 (en) 2007-10-02
WO2002078710A1 (fr) 2002-10-10
HUP0303608A3 (en) 2007-06-28
BR0208420A (pt) 2004-03-30
US20040116459A1 (en) 2004-06-17

Similar Documents

Publication Publication Date Title
NO20021329D0 (no) Kinaseinhibitorer som terapeutiske midler
NO20034176D0 (no) Pyrazolopyrimidiner som terapeutiske midler
NO20034177D0 (no) Pyrazolopyrimidiner som terapeutiske midler
NO20042955L (no) Substituerte fenylaftalener som estrogene midler
NO20035366L (no) Benzoylsulfonamider og sulfonylbenzamidiner for anvendelse som antitumormidler
NO20035775L (no) 3-fluor-pyrrolidiner som anti-diabetesmidler
DK1250047T3 (da) Herbicidt middel
DK1212327T3 (da) Pyrazolopyrimidiner som terapeutiske midler
DK1690550T3 (da) Terapeutisk middel til mesothelioma
NO20030138L (no) Lipidrikt plakkinnkapslende middel
NO20033205L (no) Terapeutiske kromanforbindelser
NO20032614L (no) Farmasöytisk sammensetning som har forbedret absorberbarhet
FI20011300A0 (fi) Sprinkleri
NO20035501D0 (no) Vaskev¶skefordelingssystem
NO20034356L (no) Terapeutisk middel for overaktiv bl¶re
NO20034358D0 (no) Terapeutisk middel for bl¶rehypersensitivitet
FI20011630A0 (fi) Karsintalaitteisto
DK1020430T3 (da) Middel indeholdende L-carnitin
NO20031239L (no) 1-amino-alkylsykloheksaner som trypanocidale midler
FR2830791B1 (fr) Nouveau support identifiable
NO20020044D0 (no) Terapeutisk middel for legemiddel-resistent hypercalcemi
IS2555B (is) 17alfa-hýdroxý-14beta-sterar með hormónavirkni
DE602004005483D1 (de) Rote bleichmittel
DK1305314T3 (da) Krystallinsk terapeutisk middel
SE0103855D0 (sv) Therapeutic agents

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application